Show simple item record

dc.contributor.advisor Bermudes, David G en Vincent, Lena en 2017-09-13T19:03:03Z 2017 en 2017-09-13 en 2017-08 en
dc.identifier.uri en
dc.description Includes bibliographical references (pages 43-49) en
dc.description.abstract Despite the advancement of numerous treatment options, conventional cancer therapeutics generally fail to prevent tumor recurrence or successfully treat metastatic cells. A promising alternative involves the use of attenuated Salmonella strains, which preferentially replicate within tumor tissue and suppress tumor growth. Although the tumor-targeted strain VNP20009 localized to some tumors with high efficiency in human clinical trials, they failed to result in eradicating cancer cells or delay tumor growth. To enhance the tumoricidal efficacy of this strain, we engineered the bacteria to express leukotoxin A (LtxA), a pore-forming multigene toxin produced by Aggregatibacter actinomycetemcomitans with natural specificity for β2-integrins found on human leukocytes. Previous studies have shown that the overexpression of this surface antigen on cancer cells is associated with increased metastatic potential, suggesting that LtxA may represent a target for metastatic tumors, which are notoriously resistant to therapy. The LtxA-encoding genes were cloned into the inducible plasmid vector pAra99a and expressed in the tumor-targeted Salmonella strain VNP20009. LtxA expression at the mRNA transcript level was verified by RT-PCR. A codon-optimized LtxA sequence was generated and tested for its ability to enhance expression in the VNP20009 background. To improve the secretion of the LtxA protein into the culture supernatant, the wild-type LtxCA was co-expressed with the E. coli hemolysin-α (HlyA) secretion complex, HlyBD. C-terminal modifications were generated to facilitate interaction of the LtxA protein with the HlyBD complex. Protein expression of the wildtype and modified LtxA constructs generated in this study could not be consistently determined by immunoblot analyses, although Columbia agar hemolysis assays suggested that active LtxA protein was functionally expressed and secreted by the wild type LtxCABD construct and an LtxCA with a modified C-terminus together with the E. coli HlyBD expressed in trans. In preliminary experiments, the human monocytic cell line THP-1 was sensitive to wildtype LtxCABD and to the C-terminal fusion constructs when co-expressed with HlyBD by VNP20009. en
dc.description.statementofresponsibility by Lena Vincent en
dc.format.extent ix, 54 pages en
dc.language.iso en en
dc.publisher California State University, Northridge en
dc.rights.uri en
dc.subject Heterologous expression en
dc.subject Leukotoxin A en
dc.subject Aggregatibacter actinomycetemcomitans en
dc.subject VNP20009 en
dc.subject Salmonella en
dc.subject Tumor-targeted bacteria en
dc.subject.other Dissertations, Academic -- CSUN -- Biology. en
dc.title Heterologous Expression and Secretion of Aggregatibacter Leukotoxin A by a Tumor-Targeted Salmonella en
dc.type Thesis en 2017-09-13T19:03:03Z
dc.description.embargoterms 2 years en 2019-09-13T19:03:03Z en
dc.contributor.department California State University, Northridge. Department of Biology en M.S. en
dc.contributor.committeeMember Summers, Michael L en
dc.contributor.committeeMember Medh, Rheem D en
dc.rights.license By signing and submitting this license, you the author grant permission to CSUN Graduate Studies to submit your thesis or dissertation, and any additional associated files you provide, to CSUN ScholarWorks, the institutional repository of the California State University, Northridge, on your behalf. You grant to CSUN ScholarWorks the non-exclusive right to reproduce and/or distribute your submission worldwide in electronic or any medium for non-commercial, academic purposes. You agree that CSUN ScholarWorks may, without changing the content, translate the submission to any medium or format, as well as keep more than one copy, for the purposes of security, backup and preservation. You represent that the submission is your original work, and that you have the right to grant the rights contained in this license. You also represent that your submission does not, to the best of your knowledge, infringe upon anyone's copyright. If the submission contains material for which you do not hold copyright, or for which the intended use is not permitted, or which does not reasonably fall under the guidelines of fair use, you represent that you have obtained the unrestricted permission of the copyright owner to grant CSUN ScholarWorks the rights required by this license, and that such third-party owned material is clearly identified and acknowledged within the text or content of the submission. If the submission is based upon work that has been sponsored or supported by an agency or organization other than the California State University, Northridge, you represent that you have fulfilled any right of review or other obligations required by such contract or agreement. CSUN ScholarWorks will clearly identify your name(s) as the author(s) or owner(s) of the submission, and will not make any alterations, other than those allowed by this license, to your submission. en

Files in this item


This item appears in the following Collection(s)

Show simple item record

Search DSpace

My Account

RSS Feeds